Skip to main content

Aziyo Biologics, Inc. (AZYO)

NASDAQ: AZYO · IEX Real-Time Price · USD
5.22 -0.32 (-5.78%)
Nov 26, 2021 1:00 PM EST - Market closed
Market Cap53.54M
Revenue (ttm)49.00M
Net Income (ttm)-21.12M
Shares Out10.26M
EPS (ttm)-2.10
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,886
Open6.20
Previous Close5.54
Day's Range5.22 - 5.33
52-Week Range5.07 - 18.20
Betan/a
AnalystsStrong Buy
Price Target14.00 (+168.2%)
Earnings DateNov 9, 2021

About AZYO

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and ...

IndustryMedical Devices
IPO DateOct 8, 2020
Employees176
Stock ExchangeNASDAQ
Ticker SymbolAZYO
Full Company Profile

Financial Performance

In 2020, AZYO's revenue was $42.68 million, a decrease of -0.51% compared to the previous year's $42.90 million. Losses were -$21.83 million, 82.8% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for AZYO stock is "Strong Buy." The 12-month stock price forecast is 14.00, which is an increase of 168.20% from the latest price.

Price Target
$14.00
(168.20% upside)
Analyst Consensus: Strong Buy

News

Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Misses Revenue Estimates

Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -32.79% and -0.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Aziyo Biologics Reports Third Quarter 2021 Financial Results

SILVER SPRING, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

2 weeks ago - GlobeNewsWire

Will Aziyo Biologics, Inc. (AZYO) Report Negative Earnings Next Week? What You Should Know

Aziyo Biologics, Inc. (AZYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for ...

SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

1 month ago - GlobeNewsWire

Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference

SILVER SPRING, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr...

2 months ago - GlobeNewsWire

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

SILVER SPRING, Md., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

2 months ago - GlobeNewsWire

Aziyo Biologics Reports Second Quarter 2021 Financial Results

SILVER SPRING, Md., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

3 months ago - GlobeNewsWire

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

SILVER SPRING, Md., July 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

4 months ago - GlobeNewsWire

Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance

SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated prod...

6 months ago - GlobeNewsWire

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

SILVER SPRING, Md., April 28, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr...

6 months ago - GlobeNewsWire

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

SILVER SPRING, Md., April 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr...

7 months ago - GlobeNewsWire

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

SILVER SPRING, Md., April 20, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr...

7 months ago - GlobeNewsWire

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

SILVER SPRING, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pr...

8 months ago - GlobeNewsWire

Aziyo Biologics to Participate in the Cowen 41st Annual Health Care Conference

SILVER SPRING, Md., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

9 months ago - GlobeNewsWire

Aziyo Biologics Announces First Patient Enrolled in HEAL Study

SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

9 months ago - GlobeNewsWire

Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021

SILVER SPRING, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

9 months ago - GlobeNewsWire

Aziyo Biologics Announces Product Design Completion for its Next Generation CanGaroo® Envelope for Implantable Electr...

SILVER SPRING, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

9 months ago - GlobeNewsWire

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibioti...

SILVER SPRING, Md., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

9 months ago - GlobeNewsWire

Aziyo Biologics Reports Third Quarter 2020 Financial Results

SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

1 year ago - GlobeNewsWire

Aziyo Biologics to Participate in the Piper 32nd Annual Virtual Healthcare Conference

SILVER SPRING, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated pro...

1 year ago - GlobeNewsWire